News

The marketing authorisation is for a new indication for the use of Arzerra (ofatumumab) in combination with chlorambucil or bendamustine to treat patients with chronic lymphocytic leukaemia (CLL)

The completed acquisition concerns products primarily intended for Asia including Japan, South Korea and Europe excluding some countries. Santen’s payment for the closed transaction totalled about $550m and

The deal aims to broaden patient access to Cimzia and make it available to patients with psoriasis, a chronic autoimmune disorder. Currently, Cimzia is not approved for the

In April 2013, GSK hired Humphrey’s Chinese corporate investigations business, ChinaWhys, to investigate who is behind a suspected smear campaign against the company. In July 2013, Humphrey and

Teva submitted this CP according to the FDA’s procedural guidance and in accordance with the Agency’s desire to facilitate public review and comment regarding new scientific data on

NAI had been named as a co-defendant in cases involving a dietary supplement called Jack3d, which contains 1,3-dimethylylamylamine (also known as DMAA), which was formulated, made for and

"LPC has been an important partner over the years and we are pleased to continue our relationship with them. This facility gives us an additional option in funding

Medicure also received an option to acquire all of the remaining issued shares of Apicore LLC and the holding company of Apicore US LLC, within the next 3

The approval follows a priority review of the Beleodaq new drug application (NDA) and was an Early Approval action prior to the 09 August 2014 PDUFA (Prescription Drug